Adding elevated Lp(a) concentration to traditional risk factors significantly enhances CV risk estimation in patients with heterozygous familial hypercholesterolaemia (HeFH), according to results of a study in 147 patients clinically diagnosed with HeFH.
Educational Partners and Supporters
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.
(Founding Partner)